Transient appearance of circulating tumor DNA associated with de novo treatment

The limitation of circulating tumor DNA (ctDNA) is its inability to detect cancer cell subpopulations with few or no dying cells. Lung cancer patients subjected to the EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment were prospectively collected, and ctDNA levels represented by the activating and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Kikuya, Uchida, Junji, Kukita, Yoji, Kumagai, Toru, Nishino, Kazumi, Inoue, Takako, Kimura, Madoka, Imamura, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146655/
https://www.ncbi.nlm.nih.gov/pubmed/27934896
http://dx.doi.org/10.1038/srep38639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146655/
https://www.ncbi.nlm.nih.gov/pubmed/27934896
http://dx.doi.org/10.1038/srep38639

Ejemplares similares